🇺🇸 FDA
Patent

US 10363232

Compositions and methods for treating severe pain

granted A61KA61K31/19A61K31/192

Quick answer

US patent 10363232 (Compositions and methods for treating severe pain) held by Infirst Healthcare Limited expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/19, A61K31/192, A61K31/194, A61K31/196